AI Verdict
LHX has stronger fundamentals based on our AI analysis.
LIMNW vs LHX Fundamental Comparison
| Metric | LIMNW | LHX |
|---|---|---|
| Revenue | N/A | $21.9B |
| Net Income | $-10.2M | $1.6B |
| Net Margin | N/A | 7.3% |
| ROE | N/A | 8.2% |
| ROA | -1,990.4% | 3.9% |
| Current Ratio | 0.05x | 1.19x |
| Debt/Equity | N/A | 0.53x |
| EPS | $-0.43 | $8.53 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
LIMNW vs LHX: Frequently Asked Questions
Is LIMNW or LHX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), LHX has stronger fundamentals. LIMNW is rated STRONG SELL (95% confidence) while LHX is rated BUY (72% confidence). This is not investment advice.
How does LIMNW compare to LHX fundamentally?
Liminatus Pharma, Inc. has ROE of N/A vs L3HARRIS TECHNOLOGIES, INC. /DE/'s 8.2%. Net margins are N/A vs 7.3% respectively.
Which stock pays higher dividends, LIMNW or LHX?
LIMNW has a dividend yield of N/A or no dividend while LHX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in LIMNW or LHX for long term?
For long-term investing, consider that LIMNW has STRONG SELL rating with 95% confidence, while LHX has BUY rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about LIMNW vs LHX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For LIMNW vs LHX, the AI consensus favors LHX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.